GenerationBio

Last week, our CEO, Geoff McDonough, participated in a fireside chat at the Needham Healthcare Conference. Geoff highlighted our innovative approach to siRNA therapeutics for T cell-driven autoimmune diseases. To view the replay, visit bit.ly/gbioevents.

We recently presented at Cold Spring Harbor Labs on our ctLNP technology for selective delivery of siRNA to T cells. We believe this breakthrough could offers new hope for treating T cell-driven autoimmune diseases. #LNP #siRNA #AutoimmuneDisease #Innovation

Today, Generation Bio's CEO Geoff McDonough, M.D., presented at the TD Cowen Health Care Conference on our innovative ctLNP-siRNA technology for T cell-driven autoimmune diseases. Catch the replay: bit.ly/gbioevents

#GenerationBio #Biotech #TDCowenConference

Today, Generation Bio announced an exciting step forward in our mission to realize the full potential of non-viral DNA therapeutics with the development of a proprietary, novel DNA called immune-quiet DNA (iqDNA). Read our press release here to learn more: buff.ly/46Tl4xV

Today, our CEO, Geoffrey McDonough, will present at the 2023 Jefferies Healthcare Conference in New York. Learn more: buff.ly/42AtjwA
#JefferiesHealthcare